Position in URGN
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$80,947,193
+$41,397,451 QoQ
Shares Held
2,199,652
0.0% QoQ
Ownership
4.50%
of shares outstanding
% of Portfolio
0.91%
of 13F equity value
Holder Rank
#5
of 190 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Derivatives in URGN
reported options exposure · as of Jun 30, 2025CallValue
$411,000
CallShares
30,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Jefferies Financial Group Inc. holds $677,219,224 across 66 Biotechnology names. URGN ranks #2 (12.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTCT |
Ptc Therapeutics, Inc.
|
1,357,042 | $110,693,915 | |
| 2 | URGN |
UroGen Pharma Ltd.
This page
|
2,199,652 | $80,947,193 | |
| 3 | IMTX |
Immatics N.V.
|
6,506,802 | $65,913,904 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
2,010,534 | $62,849,292 | |
| 5 | CGON |
CG Oncology, Inc.
|
769,947 | $54,704,734 | |
| 6 | ARGX |
Argenx SE
|
45,068 | $41,812,738 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
|
929,626 | $31,040,212 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
466,258 | $26,679,282 |
All Filings in URGN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $80,947,193 | 2,199,652 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $39,549,742 | 2,199,652 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $51,515,849 | 2,199,652 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $43,883,057 | 2,199,652 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $411,000 | 30,000 | Call | Defined | 2025-08-12 | |
| 2025-06-30 | $30,135,232 | 2,199,652 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $9,013,900 | 815,000 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $10,287,143 | 965,929 | Shares | Defined | 2025-02-27 | |
| 2024-09-30 | $12,255,500 | 965,000 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $16,192,700 | 965,000 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $12,600,000 | 840,000 | Shares | Defined | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||